Roche CEO says new drugs will offset biosimilar incursions

ZURICH (Reuters) – Swiss drugmaker Roche will be able to compensate or overcompensate for falling revenue from patent-expired drugs facing competition from rivals’ copies through its new medicines, Chief Executive Severin Schwan said on Tuesday.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *